Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:458-463

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishizawa, M.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishizawa, M.
Right arrow Articles by Saruta, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines

(Hypertension. 1997;29:458.)
© 1997 American Heart Association, Inc.


State-of-the-Art-Lecture

Improvement in Baroreflex Function by an Oral Angiotensin Receptor Antagonist in Rats With Myocardial Infarction

Masahiko Nishizawa; Hiroo Kumagai; Masashi Ichikawa; Naoki Oshima; Hiromichi Suzuki; Takao Saruta

From the Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, and the Kidney Disease Center, Saitama (Japan) Medical School (H.S.).

Correspondence to Takao Saruta, MD, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan

Impaired baroreflex function is a factor responsible for poor prognosis in myocardial infarction patients. Using logistic function curves, we calculated the maximal gain of the baroreflex control of renal sympathetic nerve activity (RSNA) and heart rate in conscious Wistar-Kyoto and spontaneously hypertensive rats whose left anterior descending artery had been ligated 4 weeks earlier. We further investigated whether 3-week oral treatment with the angiotensin II type I receptor antagonist TCV-116 would improve the baroreflex in rats with myocardial infarction. The maximal gain of the mean arterial pressure-RSNA relation in spontaneously hypertensive rats with myocardial infarction and treated with vehicle (1.7±0.1% control per mm Hg) was smaller than the gain in sham-operated hypertensive rats (2.3±0.1% control per mm Hg). After 3-week oral treatment with TCV-116, the maximal gain of the arterial pressure-RSNA relation in hypertensive rats with myocardial infarction was 2.3±0.1% control per mm Hg and significantly greater than the gain in infarcted and vehicle-treated hypertensive rats. In hypertensive rats, the maximal gain of the arterial pressure-heart rate relation of infarcted and TCV-116-treated rats was larger than in infarcted and vehicle-treated rats but significantly smaller than in sham-operated rats. These results demonstrate that oral treatment with an angiotensin receptor antagonist is effective in restoring the impaired baroreflex caused by myocardial infarction and that endogenous angiotensin II is one of the critical factors involved in the impaired baroreflex in myocardial infarction.


Key Words: baroreflex • angiotensin antagonist • myocardial infarction • sympathetic nervous system • rats • heart rate

Abbreviations: Ang II = angiotensin II • Gmax = maximal gain • HR = heart rate • MAP = mean arterial pressure • MI = myocardial infarction • RSNA = renal sympathetic nerve activity • SHR = spontaneously hypertensive rat(s) • WKY = Wistar-Kyoto rat(s)




This article has been cited by other articles:


Home page
HypertensionHome page
K. Ito, Y. Hirooka, Y. Sagara, Y. Kimura, K. Kaibuchi, H. Shimokawa, A. Takeshita, and K. Sunagawa
Inhibition of Rho-Kinase in the Brainstem Augments Baroreflex Control of Heart Rate in Rats
Hypertension, October 1, 2004; 44(4): 478 - 483.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Matsuura, H. Kumagai, A. Kawai, H. Onimaru, M. Imai, N. Oshima, K. Sakata, and T. Saruta
Rostral Ventrolateral Medulla Neurons of Neonatal Wistar-Kyoto and Spontaneously Hypertensive Rats
Hypertension, October 1, 2002; 40(4): 560 - 565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Gaudet, S. J. Godwin, and G. A. Head
Effects of central infusion of ANG II and losartan on the cardiac baroreflex in rabbits
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H558 - H566.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Murasato, Y. Harada, M. Ikeda, Y. Nakashima, and Y. Hayashida
Effect of Magnesium Deficiency on Autonomic Circulatory Regulation in Conscious Rats
Hypertension, August 1, 1999; 34(2): 247 - 252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Zhang, B. S. Huang, and F. H. H. Leenen
Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1608 - H1615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Scislo, R. A. Augustyniak, and D. S. O'Leary
Differential arterial baroreflex regulation of renal, lumbar, and adrenal sympathetic nerve activity in the rat
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R995 - R1002.
[Abstract] [Full Text] [PDF]